CLENOLIXIMAB

UNII:	78EVW7GX37
Formula:
Preferred Substance Name:	CLENOLIXIMAB

182912-58-9
CE9.GAMMA.4PE
CLENOLIXIMAB [INN]
CLENOLIXIMAB [WHO-DD]
IDEC151
IDEC-151
IMMUNOGLOBULIN G 4 (HUMAN-MACACA MONOCLONAL CE9.GAMMA.4PE .GAMMA.4-CHAIN ANTI-HUMAN ANTIGEN CD 4), DISULFIDE WITH HUMAN-MACACA MONOCLONAL CE9.GAMMA.4PE .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G 4 (HUMAN-MACACA MONOCLONAL CE9.GAMMA.4PE .GAMMA.4-CHAIN ANTI-HUMAN ANTIGEN CD 4), DISULPHIDE WITH HUMAN-MACACA MONOCLONAL CE9.GAMMA.4PE .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4, ANTI-(HUMAN CD4 (ANTIGEN)) (HUMAN-MACACA MONOCLONAL CE9.GAMMA.4PE .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MACACA MONOCLONAL CE9.GAMMA.4PE .LAMBDA.-CHAIN, DIMER

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

CLENOLIXIMAB

Synonyms and Mappings

Resources